Literature DB >> 22310732

Circulating CD4+ CD25brightFOXP3+ regulatory T-cells are significantly reduced in bullous pemphigoid patients.

P Quaglino1, E Antiga, A Comessatti, M Caproni, T Nardò, R Ponti, M Novelli, S Osella-Abate, P Fabbri, M G Bernengo.   

Abstract

Bullous pemphigoid (BP) is the most frequent autoimmune bullous skin disease, characterised by auto-antibodies against the hemidesmosome complex. Recently, regulatory T cells (Tregs) have been implicated in the development of several autoimmune diseases; few data are available in BP, failing to demonstrate a role of this subset in disease pathogenesis. The aim of this study was to investigate the expression and phenotypes of different Tregs (CD4+ CD25brightFOXP3+ and CD8+ CD28- cells) in BP to clarify whether the depletion of this subset constitutes one mechanism of tolerance loss. The CD4+ CD25brightFOXP3 and CD8+ CD28- circulating subsets were determined by flow-cytometry in 26 untreated BP patients and compared with a group of age- and sex-matched healthy controls (HC, n = 30). Absolute and percentage values of the CD4+ CD25brightFOXP3+ cells were significantly reduced in BP compared with HC (median CD25brightFOXP3+ expression within CD4+ cells: 1.8 vs. 3.5%, p = 0.002); conversely, BP patients were characterised by a significant expansion of the CD25brightFOXP3- "activated" T-cell subset. CCR4 and CD62L were expressed on the majority of CD4+ CD25brightFOXP3+ cells (75.2 and 82.3%, respectively). No differences in the CD8+ CD28- subset were found between BP and HC. This is the first report showing a significant reduction of circulating CD4+ CD25brightFOXP3+ Treg frequency in BP patients.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22310732     DOI: 10.1007/s00403-012-1213-9

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  8 in total

1.  T cell participation in autoreactivity to NC16a epitopes in bullous pemphigoid.

Authors:  W J Pickford; V Gudi; A M Haggart; B J Lewis; R Herriot; R N Barker; A D Ormerod
Journal:  Clin Exp Immunol       Date:  2015-05       Impact factor: 4.330

Review 2.  Engineered antigen-specific regulatory T cells for autoimmune skin conditions.

Authors:  Zhussipbek Mukhatayev; Yekaterina O Ostapchuk; Deyu Fang; I Caroline Le Poole
Journal:  Autoimmun Rev       Date:  2021-01-18       Impact factor: 17.390

Review 3.  BP180 Is Critical in the Autoimmunity of Bullous Pemphigoid.

Authors:  Yale Liu; Liang Li; Yumin Xia
Journal:  Front Immunol       Date:  2017-12-08       Impact factor: 7.561

4.  Mucosal Involvement in Bullous Pemphigoid Is Mostly Associated with Disease Severity and to Absence of Anti-BP230 Autoantibody.

Authors:  Ariane Clapé; Céline Muller; Grégory Gatouillat; Sébastien Le Jan; Coralie Barbe; Bach-Nga Pham; Frank Antonicelli; Philippe Bernard
Journal:  Front Immunol       Date:  2018-03-13       Impact factor: 7.561

Review 5.  Role of Regulatory Immune Cells and Molecules in Autoimmune Bullous Dermatoses.

Authors:  Tianyu Cao; Shuai Shao; Hui Fang; Bing Li; Gang Wang
Journal:  Front Immunol       Date:  2019-08-02       Impact factor: 7.561

Review 6.  Missing Insight Into T and B Cell Responses in Dermatitis Herpetiformis.

Authors:  Esko Kemppainen; Teea Salmi; Katri Lindfors
Journal:  Front Immunol       Date:  2021-03-29       Impact factor: 7.561

7.  From cellular characteristics to disease diagnosis: uncovering phenotypes with supercells.

Authors:  Julián Candia; Ryan Maunu; Meghan Driscoll; Angélique Biancotto; Pradeep Dagur; J Philip McCoy; H Nida Sen; Lai Wei; Amos Maritan; Kan Cao; Robert B Nussenblatt; Jayanth R Banavar; Wolfgang Losert
Journal:  PLoS Comput Biol       Date:  2013-09-05       Impact factor: 4.475

8.  Dysfunction of CD19+CD24hiCD27+ B regulatory cells in patients with bullous pemphigoid.

Authors:  Zhenfeng Liu; Erle Dang; Bing Li; Hongjiang Qiao; Liang Jin; Jieyu Zhang; Gang Wang
Journal:  Sci Rep       Date:  2018-01-15       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.